News
Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...
HWM surges on aerospace demand, rising earnings, and upgraded guidance, while SQM stumbles on weak results and estimate cuts.
20h
Zacks Investment Research on MSNHIMS' Subscriptions Power Personalized Care & Recurring Revenue GrowthThe renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, has cemented its position as a leading ...
Many companies have failed to disrupt the complicated U.S. healthcare market. Hims & Hers (NYSE: HIMS) may finally be ...
HIMS showcases outstanding financial strength. With just $63 million in debt against a market value of $13 billion, the ...
Telehealth platform Hims & Hers will cut 68 employees, or about 4% of its workforce, as it adjusts to a U.S. ban on ...
Explore more
As of early June, HIMS stock is hovering around $55 per share, representing a roughly 33% decline from its all-time high reached in early 2025. Indeed, Hims & Hers has subjected investors to a ...
Hims & Hers Health Inc. is cutting more than 4% of its workforce as it pivots away from selling cheap copycat versions of ...
Per the chart above, roughly 35% of Hims & Hers float is sold short. Investors who short a stock are betting its price will fall. Short interest of 10% or more is considered unusually high. Not only ...
Hims & Hers leverages ZAVA's expertise to enter Europe's weight-loss market, boosting growth and profitability. Read what ...
By Amina Niasse (Reuters) -Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results